For research use only. Not for therapeutic Use.
CX-3543 (CAT: I008859) is a selective G-quadruplex stabilizer and inhibitor of nucleolin protein. It binds to G-quadruplex DNA structures, preventing their unwinding and interfering with various cellular processes involved in DNA replication, transcription, and telomere maintenance. CX-3543 has demonstrated anti-cancer activity by inhibiting the proliferation of cancer cells, inducing apoptosis, and disrupting tumor growth in preclinical studies. Additionally, it has shown potential for sensitizing cancer cells to radiation and chemotherapy. CX-3543 represents a promising therapeutic agent for targeting G-quadruplex structures in cancer cells and is currently being investigated in clinical trials.
Catalog Number | I008859 |
CAS Number | 865311-47-3 |
Synonyms | CX-3543; Quarfloxin; Quarfloxacin; 5-fluoro-N-(2-((S)-1-methylpyrrolidin-2-yl)ethyl)-3-oxo-6-((R)-3-(pyrazin-2-yl)pyrrolidin-1-yl)-3H-benzo[b]pyrido[3,2,1-kl]phenoxazine-2-carboxamide. |
Molecular Formula | C35H33FN6O3 |
Purity | ≥95% |
Target | DNA/RNA Synthesis |
Solubility | Soluble in DMSO, not in water |
Storage | 0 - 4 °C for short term, or -20 °C for long term |
InChI | InChI=1S/C35H33FN6O3/c1-40-13-4-7-24(40)8-10-39-35(44)26-20-42-29-15-21-5-2-3-6-22(21)16-30(29)45-34-31(42)25(33(26)43)17-27(36)32(34)41-14-9-23(19-41)28-18-37-11-12-38-28/h2-3,5-6,11-12,15-18,20,23-24H,4,7-10,13-14,19H2,1H3,(H,39,44)/t23?,24-/m0/s1 |
InChIKey | WOQIDNWTQOYDLF-CGAIIQECSA-N |
SMILES | CN1CCCC1CCNC(=O)C2=CN3C4=CC5=CC=CC=C5C=C4OC6=C3C(=CC(=C6N7CCC(C7)C8=NC=CN=C8)F)C2=O |
Reference | 1. Cancer Res. 2009 Oct 1;69(19):7653-61. doi: 10.1158/0008-5472.CAN-09-1304. Epub <br> |